Skip to content

Drug interactions

Posaconazole + Ripretinib

Severity: Moderate

Posaconazole and Ripretinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole can raise exposure to ripretinib and its active metabolite, potentially increasing adverse reactions such as palmar-plantar erythrodysesthesia, hypertension and fatigue.

What this interaction means in plain words

Posaconazole and Ripretinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Posaconazole belongs to Anti Fungals; Ripretinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Posaconazole inhibits CYP3A4, which metabolizes ripretinib and its active metabolite.

What to do

Monitor closely for ripretinib toxicity and interrupt or reduce the dose if adverse reactions develop; consider an alternative antifungal with less CYP3A4 inhibition.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Posaconazole and Ripretinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Posaconazole with Ripretinib?

MediHelp rates the interaction as moderate. Posaconazole and Ripretinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Posaconazole can raise exposure to ripretinib and its active metabolite, potentially increasing adverse reactions such as palmar-plantar erythrodysesthesia, hypertension and fatigue.

How serious is the interaction between Posaconazole and Ripretinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor closely for ripretinib toxicity and interrupt or reduce the dose if adverse reactions develop; consider an alternative antifungal with less CYP3A4 inhibition.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in